Cyabra Signs $15.6M Preferred Deal With Full-Ratchet Warrants, Reprices July Warrants to $0.15
CYAB has more than doubled off its 52-week low of $0.075 on light trading volume (0.1× avg).
Summary
Cyabra signed a securities purchase agreement for a $15.6M initial closing — $10M cash plus $2.8M of cancelled debt — via Series D preferred and warrants at $0.15, with up to $30M more available over three years. The deal carries full-ratchet anti-dilution and reprices the July 2026 lead investor's 16.1M warrants to $0.15; closing still requires shareholder approval and a Nasdaq listing cure.
Key Events · Financing and Capital Events · CYAB
-
Series D Preferred Deal Signed
Initial closing of $15,610,120: $10,000,000 in new cash plus $5,610,120 of subscription consideration satisfied by cancelling $2,805,060 of outstanding debt. The Series D carries a $1,000 stated value, $0.15 conversion price and 6% cumulative dividends.
-
Full-Ratchet Anti-Dilution Terms
Both the Series D (Section 7(b)) and the new warrants (Section 3(b)) reset their conversion/exercise price down to any lower subsequent issuance price, with a one-time reset after the planned reverse split. Future discounted raises automatically hand holders more shares.
-
July Warrants Repriced to $0.15
The July 2026 lead investor's Series A warrant (8,045,980 shares) and Series B warrant (8,045,980 shares) were cut from $0.50 and $0.45 to $0.15 — 16,091,960 warrants moved from far out-of-the-money to at-the-money.
-
Up to $30M More Over Three Years
Additional tranches of $500,000 each up to $30,000,000 over three years, priced at 95% of the five lowest closing prices in the prior ten trading days, floored at $0.02. Lead Investor Alpha Capital Anstalt committed $5M within 12 months and $5M within 18 months.
Analysis · CYAB · Technology
Cyabra is raising $10M of new cash and cancelling $2.8M of debt through a Series D preferred and warrant package priced at $0.15 — roughly in line with today's $0.1556 quote. That makes it less a deep-discount bailout than a heavily dilutive financing. The real weight sits in the terms: full-ratchet anti-dilution on both the preferred and the new warrants, a one-time post-reverse-split reset, and a repricing of the July 2026 lead investor's 16.1M Series A/B warrants from $0.50/$0.45 down to $0.15. That repricing alone converts a large block of previously out-of-the-money paper into near-the-money overhang. Against a going-concern warning in the last 10-Q and a pending 1-for-2 to 1-for-30 reverse split to cure Nasdaq's $1.00 bid deficiency, the cash buys runway — but the ratchets mean future raises at lower prices hand investors more shares automatically. Closing is not done: it needs shareholder approvals and Nasdaq listing-deficiency cure, and the company has received no proceeds yet.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CYAB was trading at $0.16 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.1M. The 52-week trading range was $0.08 to $14.91. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.